$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

$nb Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000153949722001800 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$553.0K	$457.0K	$409.0K
YoY Change	-66.61%	11.74%	-4.88%
% of Gross Profit
Research & Development	$1.317M	$1.288M	$621.0K
YoY Change	168.23%	107.41%	170.0%
% of Gross Profit
Depreciation & Amortization	$0.00	$1.000K	$1.000K
YoY Change		0.0%
% of Gross Profit
Operating Expenses	$2.201M	$2.082M	$1.256M
YoY Change	-27.31%	65.76%	18.49%
Operating Profit
YoY Change
Interest Expense	$82.00K	$300.0K	-$704.0K
YoY Change	-119.07%	-142.61%	-7140.0%
% of Operating Profit
Other Income/Expense, Net		$2.000K	$0.00
YoY Change
Pretax Income	-$2.208M	-$2.554M	-$1.960M
YoY Change	-36.15%	30.31%	86.67%
Income Tax
% Of Pretax Income
Net Earnings	-$2.208M	-$2.554M	-$1.960M
YoY Change	-36.15%	30.31%	86.13%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$9.189K	-$7.522K
COMMON SHARES
Basic Shares Outstanding	279.5M shares	278.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$424.0K	$3.192M	$5.868M
YoY Change	-91.29%	-45.6%	986.67%
Cash & Equivalents	$424.0K	$3.192M	$5.868M
Short-Term Investments
Other Short-Term Assets	$112.0K	$189.0K	$294.0K
YoY Change	-59.86%	-35.71%	390.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$536.0K	$3.381M	$6.162M
YoY Change	-89.58%	-45.13%	927.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.98M	$17.01M	$17.08M
YoY Change	-0.47%	-0.39%	57.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$9.000K	$10.00K	$14.00K
YoY Change	-18.18%	-28.57%	40.0%
Other Assets	$4.373M	$2.844M	$35.00K
YoY Change	12394.29%	8025.71%	-12.5%
Total Long-Term Assets	$21.37M	$19.87M	$17.13M
YoY Change	24.88%	15.99%	57.27%
TOTAL ASSETS
Total Short-Term Assets	$536.0K	$3.381M	$6.162M
Total Long-Term Assets	$21.37M	$19.87M	$17.13M
Total Assets	$21.90M	$23.25M	$23.29M
YoY Change	-1.59%	-0.18%	102.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$739.0K	$467.0K	$103.0K
YoY Change	297.31%	353.4%	-95.34%
Accrued Expenses	$1.155M	$852.0K	$279.0K
YoY Change	231.9%	205.38%	-62.8%
Deferred Revenue
YoY Change
Short-Term Debt	$2.000M	$2.000M	$2.000M
YoY Change	0.0%	0.0%	-47.64%
Long-Term Debt Due	$502.0K	$755.0K	$396.0K
YoY Change		90.66%	-64.32%
Total Short-Term Liabilities	$7.088M	$6.511M	$2.778M
YoY Change	179.72%	134.38%	-64.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$6.599M
YoY Change	-100.0%	-100.0%	2438.08%
Other Long-Term Liabilities	$0.00	$0.00	$86.00K
YoY Change	-100.0%	-100.0%	-46.25%
Total Long-Term Liabilities	$0.00	$0.00	$6.685M
YoY Change	-100.0%	-100.0%	1491.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.088M	$6.511M	$2.778M
Total Long-Term Liabilities	$0.00	$0.00	$6.685M
Total Liabilities	$7.088M	$6.511M	$9.463M
YoY Change	3.29%	-31.2%	13.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$115.2M	-$113.0M	-$101.0M
YoY Change	10.21%	11.79%
Common Stock	$131.0M	$130.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.81M	$16.74M	$13.83M
YoY Change
Total Liabilities & Shareholders Equity	$21.90M	$23.25M	$23.29M
YoY Change	-1.59%	-0.18%	102.69%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.208M	-$2.554M	-$1.960M
YoY Change	-36.15%	30.31%	86.13%
Depreciation, Depletion And Amortization	$0.00	$1.000K	$1.000K
YoY Change		0.0%
Cash From Operating Activities	-$2.386M	-$1.738M	-$1.609M
YoY Change	76.87%	8.02%	44.95%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$16.00K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$21.00K
YoY Change
Cash From Investing Activities	$21.00K		-$16.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-526.0K	-$21.00K	346.0K
YoY Change	-275.92%	-106.07%	-74.37%
NET CHANGE
Cash From Operating Activities	-2.386M	-$1.738M	-1.609M
Cash From Investing Activities	21.00K		-16.00K
Cash From Financing Activities	-526.0K	-$21.00K	346.0K
Net Change In Cash	-2.891M	-$2.088M	-1.279M
YoY Change	175.33%	63.25%
FREE CASH FLOW
Cash From Operating Activities	-$2.386M	-$1.738M	-$1.609M
Capital Expenditures	$0.00	$0.00	-$16.00K
Free Cash Flow	-$2.386M	-$1.738M	-$1.593M
YoY Change	76.87%	9.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001512228
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	NioCorp Developments Ltd.
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings		usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q3	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2554000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-112951000	usd
CY2022Q3	us-gaap	Capital Expenditure Discontinued Operations CapitalExpenditureDiscontinuedOperations	109005000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent		usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent		usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022Q3	niobf	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted		shares
CY2022Q3	niobf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised		shares
CY2022Q3	niobf	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired		shares
CY2022Q3	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	5000001	usd
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Entity File Number EntityFileNumber	000-55710
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1262185
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	7000 South Yosemite Street
CY2022Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 115
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Centennial
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
CY2022Q3	dei	City Area Code CityAreaCode	855
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	264-6267
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	279450884	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3192000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5280000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	189000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	402000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	3381000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	5682000	usd
CY2022Q3	us-gaap	Deferred Costs DeferredCosts	2809000	usd
CY2022Q3	us-gaap	Deposits Assets DepositsAssets	35000	usd
CY2022Q2	us-gaap	Deposits Assets DepositsAssets	35000	usd
CY2022Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	10000	usd
CY2022Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	10000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	76000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	94000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	850000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	850000	usd
CY2022Q3	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2022Q2	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2022Q3	us-gaap	Assets Assets	23246000	usd
CY2022Q2	us-gaap	Assets Assets	22756000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3670000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	817000	usd
CY2022Q3	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	2000000	usd
CY2022Q2	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	2000000	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	755000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2169000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6511000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5068000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	6511000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5091000	usd
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	279393227	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	276670606	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	130684000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	129055000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-112951000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110397000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-998000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-993000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16735000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23246000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22756000	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	293000	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	319000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	164000	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	90000	usd
CY2022Q3	niobf	Exploration Expenditures ExplorationExpenditures	1288000	usd
CY2021Q3	niobf	Exploration Expenditures ExplorationExpenditures	621000	usd
CY2022Q3	us-gaap	Other General Expense OtherGeneralExpense	337000	usd
CY2021Q3	us-gaap	Other General Expense OtherGeneralExpense	226000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2082000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1256000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-173000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2554000	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-225000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	300000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	605000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	1000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-2000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2554000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2088000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2554000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-5000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	124000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2559000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1964000	usd
CY2022Q3	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.01
CY2021Q3	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.01
CY2022Q3	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	277926316	shares
CY2021Q3	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	258023048	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2554000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1000	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
CY2022Q3	us-gaap	Accretion Expense AccretionExpense	236000	usd
CY2021Q3	us-gaap	Accretion Expense AccretionExpense	551000	usd
CY2022Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-2000	usd
CY2021Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-1000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	1000	usd
CY2022Q3	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-177000	usd
CY2021Q3	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-288000	usd
CY2022Q3	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-2143000	usd
CY2021Q3	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-1247000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-209000	usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	270000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	196000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-92000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1738000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1609000	usd
CY2021Q3	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	16000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	664000	usd
CY2022Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21000	usd
CY2021Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	318000	usd
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet	40000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	346000	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-329000	usd
CY2021Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-170000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2088000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1449000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5280000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7317000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3192000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5868000	usd
CY2022Q3	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	1650000	usd
CY2021Q3	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	1350000	usd
CY2022Q3	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	2809000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
CY2021Q3	niobf	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	543000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	121000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1350000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	124000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13263000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1650000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-21000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2554000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16735000	usd
CY2022Q3	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_803_eus-gaap--NatureOfOperations_zdtSkK7pO1t1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_82C_zx1KnZ1EgwS">DESCRIPTION OF BUSINESS</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">NioCorp Developments Ltd. (“NioCorp” or the “Company”) was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in <span id="xdx_905_eus-gaap--NumberOfReportableSegments_dxL_uN_c20220701__20220930_zf88vXXG3O8d" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0381">one</span></span> reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the “Elk Creek Project”) located in southeastern Nebraska.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company's ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining additional financing and maintaining continued support from its shareholders and creditors. </p>
CY2022Q3	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_800_eus-gaap--BasisOfAccounting_zbXr9S6cdCH6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_826_z89gGVJYapl8">BASIS OF PREPARATION</span></span></td></tr> </table> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zm5tICJsxp23" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">a)</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_863_zaxuVAB7DeWa">Basis of Preparation and Consolidation</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles of the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). The interim condensed consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited consolidated financial statements for the year ended June 30, 2022. Certain transactions include reference to Canadian dollars (“C$”) where applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the opinion of management, all adjustments considered necessary (including reclassifications and normal recurring adjustments) for a fair statement of the financial position, results of operations, and cash flows at September 30, 2022, and for all periods presented, have been included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to appropriate SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended June 30, 2022. The interim results are not necessarily indicative of results for the full year ending June 30, 2023, or future operating periods.</p> <p id="xdx_853_z345ENS5Zqa3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zdWmgcedMSo8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">b)</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_865_z2MaQTnrRaSc">Recent Accounting Standards</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration: underline">Issued and Adopted</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. ASU 2020-06 removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company’ s current financial position, results of operations or financial statement disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"/> <p style="margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration: underline">Issued and Not Effective</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a material impact on the Company’s consolidated financial statements upon adoption.</p> <p id="xdx_856_zbRzWH7Yp9J8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--UseOfEstimates_zkBjXtUKKXha" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_868_zS7HV2gXnGHc">Use of Estimates</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p> <p id="xdx_859_zy1vwyAqoK17" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_ziaNO0PUGQ0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">d)</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_86B_z5NIyve8skDg">Basic and Diluted Earnings per Share</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic net loss per share is computed by dividing net loss by the weighted average number of Common Shares outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted-average number of Common Share equivalents outstanding for the period determined using the treasury stock method or the if-converted method, as applicable. For purposes of this calculation, options to purchase Common Shares (“Options”) and warrants to purchase Common Shares (“Warrants”) are considered to be Common Share equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive. The following shares underlying Options, Warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation as indicated below.</p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_ztZW7b2Tk6qg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zERquQgOan01" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-right: 0.7pt; text-align: right"> </td> <td style="padding-right: 0.7pt"> </td> <td style="padding-right: 0.7pt; text-align: center"> </td> <td style="padding-right: 0.7pt; text-align: center"> </td> <td style="padding-right: 0.7pt; text-align: center"> </td> <td style="padding-right: 0.7pt; text-align: center"> </td> <td style="padding-right: 0.7pt; text-align: center"> </td> <td style="padding-right: 0.7pt; text-align: center"> </td> <td style="padding-right: 0.7pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 0.7pt; text-align: right"> </td> <td style="padding-right: 0.7pt"> </td> <td colspan="6" style="padding-right: 0.7pt; text-align: center"><span style="font-size: 10pt">For the three months ended September 30,</span></td> <td style="padding-right: 0.7pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 0.7pt"><span style="font-size: 10pt">Excluded potentially dilutive securities <sup id="xdx_F66_zsrcl1BdUgu4">(1)</sup>: </span></td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 0.7pt; text-align: right"><span style="font-size: 10pt">2022</span></td> <td style="padding-bottom: 1pt; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: right"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 0.7pt; text-align: right"><span style="font-size: 10pt">2021</span></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 72%; padding-right: 0.7pt"><span style="font-size: 10pt">Options</span></td> <td style="width: 1%; padding-right: 0.7pt"> </td> <td style="width: 1%; padding-right: 0.7pt"> </td> <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20220930_fKDEp_zGdmPKwSwRY9" style="width: 11%; padding-right: 0.7pt; text-align: right" title="Options"><span style="font-size: 10pt">14,464,000</span></td> <td style="width: 1%; padding-right: 0.7pt"> </td> <td style="width: 1%; padding-right: 0.7pt"> </td> <td style="width: 1%; padding-right: 0.7pt"> </td> <td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20210930_fKDEp_zITqdOkSc7Jg" style="width: 11%; padding-right: 0.7pt; text-align: right"><span style="font-size: 10pt">15,225,000</span></td> <td style="width: 1%; padding-right: 0.7pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 0.7pt"><span style="font-size: 10pt">Warrants</span></td> <td style="padding-right: 0.7pt"> </td> <td style="padding-right: 0.7pt"> </td> <td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20220930_fKDEp_zSoCeGpABKU7" style="padding-right: 0.7pt; text-align: right" title="Warrants"><span style="font-size: 10pt">18,516,253</span></td> <td style="padding-right: 0.7pt"> </td> <td style="padding-right: 0.7pt"> </td> <td style="padding-right: 0.7pt"> </td> <td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20210930_fKDEp_zgTnIj4HfjK9" style="padding-right: 0.7pt; text-align: right"><span style="font-size: 10pt">13,470,118</span></td> <td style="padding-right: 0.7pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt"><span style="font-size: 10pt">Convertible debt</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 0.7pt"> </td> <td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20220930_fKDEp_zXi9AcrCBiN" style="border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right" title="Convertible debt"><span style="font-size: 10pt">1,030,000</span></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 0.7pt"> </td> <td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20210930_fKDEp_zCYqBHElWip1" style="border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right"><span style="font-size: 10pt">14,744,000</span></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><span style="font-size: 10pt">Total potential dilutive securities</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-right: 0.7pt"> </td> <td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_uShares_c20220701__20220930_fKDEp_zMCe7zt0R702" style="border-bottom: Black 1.5pt solid; padding-right: 0.7pt; text-align: right" title="Total potential dilutive securities"><span style="font-size: 10pt">34,010,253</span></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-right: 0.7pt"> </td> <td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_uShares_c20210701__20210930_fKDEp_ze0PPj6lren3" style="border-bottom: Black 1.5pt solid; padding-right: 0.7pt; text-align: right"><span style="font-size: 10pt">43,439,118</span></td> <td style="padding-bottom: 1pt"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.35in; text-align: justify"><span style="font-size: 10pt">(<i id="xdx_F05_zxWytTzSxWZ3">1</i>)</span></td> <td style="text-align: justify"><span id="xdx_F12_zF94VUNpAcYa" style="font-size: 10pt">The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have <i>not</i> been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.</span></td></tr> </table> <p id="xdx_8A9_zv2aSQp9h1wa" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_829_zCtux5Xd2ywl">RESTATEMENT</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As previously reported, the Company restated its consolidated balance sheets as of June 30, 2022 and 2021, and consolidated statements of operations and comprehensive income, equity and cash flows for the years ended June 30, 2022 and 2021. In addition, the restatement impacted the first, second and third quarters of our fiscal year ended June 30, 2022. The summarized restatement impacts for the comparable interim period in fiscal year 2022 are presented below. The restatement corrects errors related to the accounting for the unamortized deferred financing costs and debt discounts upon extinguishments of debt related to debt conversions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">.</p> <p id="xdx_893_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zhALAubwQgea" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span><span id="xdx_8BE_zRmwEj1YO5M3" style="display: none; visibility: hidden">Restatement Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Restatement Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>For the Three Months Ended September 30, 2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_491_20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHD7M4xn7jI" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_49A_20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwKVxC26Z9Df" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_49B_20210701__20210930_zZPHDPbMsre5" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">For the three months ended September 30, 2021</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously Reported</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Restatement <br/> Impacts</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Restated</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_iN_di_zjFyVZBw87oe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 5.4pt">Foreign exchange loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">210</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">15</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">225</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InterestExpense_zwc7yUiKDs6g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">605</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_di_zDExf6g2qmH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Loss before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,960</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,088</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLoss_iN_di_zGIMXmDM1dng" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,960</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,088</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_iN_di_z7BSKG86CbXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Reporting currency translation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(109</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(15</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(124</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--ComprehensiveIncomeNetOfTax_iN_di_zuehkToNcjhi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Total comprehensive loss</td><td> </td> <td style="text-align: left"/><td style="text-align: right">1,851</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"/><td style="text-align: right">113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"/><td style="text-align: right">1,964</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8B2_zP4EjdAWVKra" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_89E_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zm3rqvMJiuzj" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B1_zKL82qlANXm3" style="display: none; visibility: hidden">Restatement Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited)</span><span/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Restatement Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>For the Three Months Ended September 30, 2021</b></span></p> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td> <td id="xdx_491_20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zevbbEaotQ3k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td> <td id="xdx_49A_20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember_z5aaYMgVZZAb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td> <td id="xdx_492_20210701__20210930_zXGLUhzpprk4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously Reported</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Restatement <br/> Impacts</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Restated</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zMBIatGQReo4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">CASH FLOWS FROM OPERATING ACTIVITIES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_i01_zwvm0qAiygGd" style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-left: 5.4pt">Total loss for the period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(1,960</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(128</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(2,088</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--AccretionExpense_i02_zSGiF50cKtRi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in">Accretion of convertible debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">438</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">551</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--ForeignCurrencyTransactionGainLossBeforeTax1_i02N_di_zr04rC6m1Ix2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in">Foreign exchange loss </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">273</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A9_zHaf4A3EC5E" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zV6nSM77JWC6" style="margin-top: 0; margin-bottom: 0"><span><span id="xdx_8B0_zBayDrQ5Msn9" style="display: none; visibility: hidden">Restatement Impact to the Condensed Consolidated Statement of Shareholders' Equity (unaudited)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Restatement Impacts to the Condensed Consolidated Statement of Shareholders' Equity (unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>For the Three Months Ended September 30, 2021</b></span></p> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously <br/> Reported</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Restatement <br/> Impacts</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Restated</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">June 30, 2021 opening balance adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-indent: 8.25pt; padding-left: 5.4pt">Deficit</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquity_iS_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zO9wEvtHy3fl" style="width: 10%; text-align: right" title="Beginning balance">(99,076</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zNRAaa8BgBag" style="width: 10%; text-align: right" title="Beginning balance">(434</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--StockholdersEquity_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zfq2v2fGLwC1" style="width: 10%; text-align: right" title="Beginning balance">(99,510</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Accumulated other comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockholdersEquity_iS_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zOU5K3nQTbj2" style="text-align: right" title="Beginning balance">(1,143</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockholdersEquity_iS_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zhL96caU6AD7" style="text-align: right" title="Beginning balance">(16</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zEuR1jlJnnCl" style="text-align: right" title="Beginning balance">(1,159</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Total Shareholders’ equity</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockholdersEquity_iS_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zhw55nEePtbl" style="text-align: right" title="Beginning balance">13,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKe69ht6z2ed" style="text-align: right" title="Beginning balance">(450</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_c20210701__20210930_zA2SyxCbmuJg" style="text-align: right" title="Beginning balance">13,213</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Activity adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Loss for the period</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFMNyFgr7zTk" style="text-align: right" title="Loss for the period">(1,960</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1l6g0Hvstri" style="text-align: right" title="Loss for the period">(128</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20210701__20210930_z6s2afaVd6ih" style="text-align: right" title="Loss for the period">(2,088</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Reporting currency translation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVwJ7Q2hcNkl" style="text-align: right" title="Reporting currency presentation">109</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMFhm0eGMNH9" style="text-align: right" title="Reporting currency presentation">15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20210701__20210930_ziCi9GiTpHV2" style="text-align: right" title="Reporting currency presentation">124</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">September 30, 2021 ending balance adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 8.25pt; padding-left: 5.4pt">Deficit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_ztX6YVIxu8Ya" style="text-align: right" title="Ending balance">(101,036</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockholdersEquity_iE_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zEM2x27Mjfl2" style="text-align: right" title="Ending balance">(562</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockholdersEquity_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zK9xh0hYtkh7" style="text-align: right" title="Ending balance">(101,598</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Accumulated other comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_z1ZInYippQ5f" style="text-align: right" title="Ending balance">(1,034</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zdoTm0JFygP6" style="text-align: right" title="Ending balance">(1</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockholdersEquity_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zAYXTPmUvVif" style="text-align: right" title="Ending balance">(1,035</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Total equity</td><td> </td> <td style="text-align: left"/><td id="xdx_986_eus-gaap--StockholdersEquity_iE_c20210701__20210930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8HT0SF4A1kf" style="text-align: right" title="Ending balance">13,826</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"/><td id="xdx_987_eus-gaap--StockholdersEquity_iE_c20210701__20210930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zzYbNUyHuDCj" style="text-align: right" title="Ending balance">(563</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"/><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_c20210701__20210930_zkGNCRr9vgy8" style="text-align: right" title="Ending balance">13,263</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_ze0uvMP3ibOf" style="margin-top: 0; margin-bottom: 0"> </p>
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	124000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1964000	usd
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	14744000	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	34010253	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43439118	shares
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-225000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	605000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2088000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2022Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zkBjXtUKKXha" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_868_zS7HV2gXnGHc">Use of Estimates</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p>
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	14464000	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	15225000	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	18516253	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	13470118	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1030000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2021Q3	us-gaap	Accretion Expense AccretionExpense	551000	usd
CY2021Q3	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-288000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	124000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13263000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2088000	usd
CY2022Q3	niobf	Working Capital WorkingCapital	3130000	usd
CY2022Q3	niobf	Cash And Cash Equivalents At Carrying Value1 CashAndCashEquivalentsAtCarryingValue1	3192000	usd
CY2022Q3	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	<p id="xdx_805_eus-gaap--DeferredPolicyAcquisitionCostsTextBlock1_zf7MrO0NbaWk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">5.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_82D_z5nLrCQuVzU6">DEFERRED TRANSACTION COSTS</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has deferred third-party costs, including legal fees, other professional and consulting fees, and due diligence fees, incurred in connection with the proposed transaction discussed in Note 13. These costs are deferred until closing, at which time a portion of the costs will be recorded against convertible debt to be entered into in connection with the proposed transaction, with the remainder treated as a reduction to the value of Common Shares issued.</p>
CY2022Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2904000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	115000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	467000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	654000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	200000	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	51000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3670000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	817000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	815000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14464000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14464000	shares
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	14464000	shares
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	14464000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18516253	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18516253	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18516253	shares
CY2022Q3	us-gaap	Exploration Expense ExplorationExpense	1288000	usd
CY2021Q3	us-gaap	Exploration Expense ExplorationExpense	621000	usd
CY2022Q3	niobf	Fixed Rent Expense FixedRentExpense	21000	usd
CY2021Q3	niobf	Fixed Rent Expense FixedRentExpense	21000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	3000	usd
CY2021Q3	us-gaap	Variable Lease Cost VariableLeaseCost	2000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
CY2021Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
CY2022Q3	us-gaap	Sublease Income SubleaseIncome	6000	usd
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	5000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	20000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	23000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	93000	usd
CY2022Q3	niobf	Less Amount Of Payments Representing Interest LessAmountOfPaymentsRepresentingInterest	7000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	86000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	3192000	usd
CY2022Q3	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	10000	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3202000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5280000	usd
CY2022Q2	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	10000	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5290000	usd
CY2022Q3	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	65000000.0	usd
CY2022Q3	us-gaap	Cash Cash	15000000.0	usd
CY2022Q3	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.15	pure
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5000000.0	usd
CY2022Q3	us-gaap	Regulatory Liabilities RegulatoryLiabilities	200000	usd

Files In Submission

Name	View Source	Status
0001539497-22-001800-index-headers.html	Edgar Link	pending
0001539497-22-001800-index.html	Edgar Link	pending
0001539497-22-001800.txt	Edgar Link	pending
0001539497-22-001800-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
n2574_x61-10q.htm	Edgar Link	pending
n2574_x61-g001.jpg	Edgar Link	pending
n2574_x61ex31-1.htm	Edgar Link	pending
n2574_x61ex31-2.htm	Edgar Link	pending
n2574_x61ex32-1.htm	Edgar Link	pending
n2574_x61ex32-2.htm	Edgar Link	pending
niobf-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
niobf-20220930_cal.xml	Edgar Link	unprocessable
niobf-20220930_def.xml	Edgar Link	unprocessable
niobf-20220930_lab.xml	Edgar Link	unprocessable
niobf-20220930_pre.xml	Edgar Link	unprocessable
n2574_x61-10q_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

2022 Q4 Form 10-Q Financial Statement

#000153949722001800 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB NIOCORP DEVELOPMENTS LTD Stock $nb

2022 Q4 Form 10-Q Financial Statement

#000153949722001800 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb